Sophia Smith scores twice for US in in 3

UnitedStates'AlexMorgan(13)andSavannahDeMelo(9)celebrateagoalbyteammateSophiaSmithduringthefirsthalf 1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint




comprehensive

author：knowledge    Page View：53665

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

advertisement

Featured Speakers

  • Irena Melnikova, Ph.D., partner, Pfizer Ventures
  • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
  • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio
Next article： Sports medicine is finally prioritizing gender equality